You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 124 No. 5, November 1969 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  ARTICLES
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (31)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Propranolol in Angina Pectoris

Thomas T. Zsotér, MD; Donald S. Beanlands, MD

Arch Intern Med. 1969;124(5):584-587.


Abstract



Twenty patients with angina pectoris received propranolol hydrochloride at two dosage levels and placebo in a double-blind trial. The lower dosage of propranolol hydrochloride (80 mg/day) failed to reduce the frequency of anginal attacks. The higher dosage of propranolol hydrochloride (160 mg/day), however, decreased the number of daily pain episodes in 17 patients and the amount of nitroglycerin consumed (P <0.02). No correlation was found between the response to the drug and the left ventricular end diastolic (LVED) pressure measured prior to the drug trial. Propranolol was effective also in patients with severe coronary disease judged from coronary angiography, but there was a trend toward better results in patients with less severe involvement of the coronary arteries. Exercise tolerance became greater on the regimen of propranolol. Adverse effects were never severe enough to warrant stopping the trial.



Author Affiliations



Toronto

From the Department of Medicine, University of Toronto, and the subdepartments of clinical pharmacology and; cardiology of the Department of Medicine, Toronto Western Hospital.


Footnotes



Received for publication Jan 9, 1969; accepted May 8.

Reprint request to 399 Bathurst St, Toronto 2B (Dr. Zsotér).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Withdrawal Syndromes and the Cessation of Antihypertensive Therapy
Hart and Anderson
Arch Intern Med 1981;141:1125-1127.
ABSTRACT  

Hypersensitivity to Adrenergic Stimulation after Propranolol Withdrawal in Normal Subjects
BOUDOULAS et al.
ANN INTERN MED 1977;87:433-436.
ABSTRACT  

Abrupt Propranolol Withdrawal and Myocardial Contractility: A Study of Effects in Normal Man
Pantano and Lee
Arch Intern Med 1976;136:867-871.
ABSTRACT  

Current Medical Practice and the Food and Drug Administration: Some Evidence for the Existing Gap
Mundy et al.
JAMA 1974;229:1744-1748.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1969 American Medical Association. All Rights Reserved.